Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04514003 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Corona and COVID-19 Study in Telemark and Agder

Study acronym: COVITA
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2023 to Dec 31, 2026v6
  2. Enrollment target: 5000 to 1200
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  3. 2 versions Re-verified since Sep 27, 2021, no change to tracked fieldsv3-v4
  4. Eligibility criteria expanded, about 2 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Through SARS-CoV-2 IgG testing of PCR positive and negative cases the study will follow the COVID-19 immune response by monitoring the SARS-CoV-2 IgG antibody levels over a period of two years. Further, risk factors will be identified by the use of the test-negative design including population controls, allowing comparison of participants with positive and negative tests, and with population controls (triangulation). Special emphasis will be on high risk groups in general and on different occupational, environmental and socio-economic groups in particular. Finally, severity of illness, deaths and the use of health care during will be assessed using national register data from Telemark and Agder.
Trial Details
NCT Number NCT04514003
Lead Sponsor Sykehuset Telemark
Collaborators: Sorlandet Hospital HF, Norwegian Institute of Public Health, London School of Hygiene and Tropical Medicine, Leiden University, Aalborg University
Conditions
(from sponsor)		 Covid19
Related terms COVID-19
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov